Maxwell
Maxwell Bertolero, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110166883 | Systems and Methods for Modeling Healthcare Costs, Predicting Same, and Targeting Improved Healthcare Quality and Profitability - A comprehensive healthcare analytic and predicative modeling system that tracks costs for patients on a long term basis (greater than 6 months, one-year, or more) to assess the long-term effectiveness of various treatment options. Based upon the evaluation of the long-term effectiveness of various treatment options, the system then delivers a predictive model, which is based on data extracted and aggregated from dissimilar databases, that analyzes up-to-date economic and clinical outcomes, and then, using this data, can estimate long-term future treatment results from an economic and clinical perspective. Also disclosed herein is a personal electronic medical record on a computer network created by a medical provider on the authorization of the patient and controlled by the patient. Lastly, disclosed herein is a computer system for the consolidation of medical and financial data from disparate databases into a unitary data format. | 07-07-2011 |
Maxwell Bogue, Hong Kong HK
Patent application number | Description | Published |
---|---|---|
20160031141 | HAND-HELD THREE-DIMENSIONAL DRAWING DEVICE - A three-dimensional (3D) drawing device having a housing configured for manipulation by a user's hand and to accept a feed stock that is, in certain embodiments, a strand of thermoplastic. The drawing device has a nozzle assembly with an exit nozzle and a motor connected to a gear train that engages the strand of thermoplastic feed stock such that rotation of the motor causes the feed stock to be extruded out of the exit nozzle to form a three-dimensional object. | 02-04-2016 |
Maxwell Brustmeyer, East Northport, NY US
Patent application number | Description | Published |
---|---|---|
20100148434 | CARD-GUIDED PROJECTILE AND TARGET GAME - A card-guided projectile and target game includes a game surface having first and second opposite ends. The game surface extends between the ends. The game surface includes indicia for delineating regions of the surface. At least one projectile, at least one projectile receiver, and at least one playing card includes indicia for in-game card guided play of a beverage drinking game. | 06-17-2010 |
Maxwell Casely-Hayford, Chatham GB
Maxwell Dickison, Adelaide AU
Patent application number | Description | Published |
---|---|---|
20120025041 | Louvre mounting assembly - A sealing member for a louvre mounting assembly is described. The louvre mounting assembly is of the type to allow co-rotation of at least first and second louvre panes between open and closed positions. The sealing member located in an end clip for the first louvre pane of the louvre mounting assembly, wherein the sealing member includes a first sealing region for sealing against a portion of the second louvre pane to seal against movement of liquid into the end clip when the louvre mounting assembly is in a closed position. | 02-02-2012 |
20120073771 | Screen retention assembly - A retention assembly for securing an edge portion of a screen to a surround arrangement is disclosed where the surround arrangement includes a receiving channel to receive the edge portion of the screen and the receiving channel is formed by first and second opposed wall portions. The retention includes an engagement member to secure the received edge portion of the screen in the receiving channel, the engagement member having a substantially planar surface and an opposed wedging surface, wherein on insertion of the engagement member into the receiving channel, the wedging surface of the engagement member bears against a complementary wedging surface on the first wall portion of the receiving channel to capture and secure the edge portion between the second wall portion of the receiving channel and the substantially planar surface of the engagement member, and wherein upon further insertion of the engagement member into the receiving channel the engagement member releases to allow the edge portion to be removed from the receiving channel. | 03-29-2012 |
20130299541 | SUPPORT ARRANGEMENT FOR AN IMPLEMENT - This invention relates to a support arrangement for an implement such as a metal detector, the support arrangement comprising a harness worn by a user, the harness comprising an attachment point for a first load-bearing element transferring a load associated with the implement to the attachment point, and a second load-bearing element transferring the load from the attachment point to a further point on the harness. | 11-14-2013 |
Maxwell Kotlarchyk, Costa Mesa, CA US
Patent application number | Description | Published |
---|---|---|
20120272745 | CONCENTRATION INDEPENDENT MODULATION OF LOCAL MICROMECHANICS IN A FIBRIN GEL - An apparatus and method for providing a gradient strain to an extracellular matrix to induce mechanotransduction. The gradient strain can be produced by adhering the extracellular matrix to a post and the walls of a sample holder, and then rotating the post and the sample holder. This strain can result in increased stiffness of the extracellular matrix with very little loss of pore size. | 11-01-2012 |
Maxwell Murialdo, Westminster, CA US
Patent application number | Description | Published |
---|---|---|
20140113811 | NANOSTRUCTURED CARBON MATERIALS FOR ADSORPTION OF METHANE AND OTHER GASES - Provided are methods for storing gases on porous adsorbents, methods for optimizing the storage of gases on porous adsorbents, methods of making porous adsorbents, and methods of gas storage of optimized compositions, as in systems containing porous adsorbents and gas adsorbed on the surface of the porous adsorbent. The disclosed methods and systems feature a constant or increasing isosteric enthalpy of adsorption as a function of uptake of the gas onto the exposed surface of a porous adsorbent. Adsorbents with a porous geometry and surface dimensions suited to a particular adsorbate are exposed to the gas at elevated pressures in the specific regime where n/V (density) is larger than predicted by the ideal gas law by more than several percent. | 04-24-2014 |
Maxwell Opoku Agyemang, South Miami, FL US
Patent application number | Description | Published |
---|---|---|
20140333104 | MOMS CAR SEAT - The pregnant passenger and fetus have many intrinsic combinations of risk factors making them vulnerable to pregnancy loss and possible death during vehicle accidents. In most cases of fetal loss in motor vehicle accidents the cause was placenta abruption. It takes very little changes in force for the placental tissues to separate. Seat belt in the pelvis area is a suspicious culprit even though it will take highly complex computer and experimental models to substantiate this. The fact of traditional seat belts in any close proximity of the pregnancy leaves us to question if it is paradoxically not the cause such high restraining pressures on the pregnancy. | 11-13-2014 |
20140333105 | SAFETY SEAT FOR PREGNANT MOTHER - A passenger seat and safety belt system in accordance with the principles of the invention provides a comfortable seat having two straps that adjustably and safely restrain the passenger. A restraining mechanism, for example a buckle, may cross over the chest just above the nipple line connecting the two straps. This may provide a comfortable seat for the mother and safe protection for both her and the fetus. The seat may include an attaching mechanism that securely fastens it to the seatbelts of a vehicle. | 11-13-2014 |
20150011923 | Ortho Shoulder Ball - Shoulder pain is a common problem encountered in many medical practices. There is a protean source of such pain including adhesive capsulities, rotator cuff injuries, fractures, muscle sprains and strains. In all of these; pain is worsened by any weight-bearing on the affected shoulder during the acute or recovery phase of the injury. In some cases, shoulder pain results exclusively from frequent sleeping on one shoulder. | 01-08-2015 |
20150182335 | LEFT VENTRICULAR OUTFLOW DEVICE (LVODe) - Left Ventricular Outflow Device (LVODe) is a medical apparatus implanted to enable normal flow from the left ventricle to the aorta in hypertrophic cardiomyopathy. Hypertrophic cardiomyopathy (HCM) is a congenital disease of the heart with heterogenic genetic phenotypes that result in obstructed flow to the aorta. Echocardiography characterizes HCM as having left ventricular wall thickness greater than 25 mm, asymmetric hypertrophy, left ventricular outflow obstruction, systolic anterior motion of the mitral valve. Patients present with sudden death, perilous arrhythmias, anginal symptoms, and exertional dyspnea. Treatments used for HCM are medical therapy, surgical myectomy and alcohol septal ablation; which are not without adverse effects. In addition, the structural variation of HCM makes no one particular treatment the magic bullet. | 07-02-2015 |
Maxwell Opoku Agyemang, Miami, FL US
Patent application number | Description | Published |
---|---|---|
20150286781 | PACEMAKER ICD ELECTRONIC HEALTH RECORD - This invention concerns a novel practical application of using secured electronic form of medical record keeping in protecting and securing patient privacy specifically and only in regards to information pertaining to patients' pacemaker and or icd data or interrogation record. | 10-08-2015 |
Maxwell Poper, Westminster, CA US
Patent application number | Description | Published |
---|---|---|
20130011564 | CLEANSING PAD - A method of manufacturing a personal cleansing device that has a pourable sodium soap impregnated substantially throughout the interior thereof and produces lather in hard water as well as soft water. The method comprises the steps of: providing a pourable sodium soap having a melting point of 120° F. to 160° F. that is in essentially solid form at a first temperature, and in essentially pourable molten form at a second temperature; heating the pourable sodium soap to the second temperature such that the pourable sodium soap is in pourable molten form; applying the molten pourable sodium soap to one or more portions of a substrate comprised of web of fibers; and allowing the pourable sodium soap to cool down to the first temperature to resolidify within interstitial spaces between the fibers of the substrate. The pourable sodium soap comprises at least one sodium soap and 5% to 35% glycerine. | 01-10-2013 |
Maxwell Postow, Rockville, MD US
Patent application number | Description | Published |
---|---|---|
20110011764 | Combination daily reminder and holder for medicinals - A product or device for holding medicinals, and serving as a convenient daily reminder to the user to take the medicinals at prescribed periodic intervals. The device comprises a board having ridges or slots on each side, with the ridges or slots arranged in a saw-tooth configuration. Indicia are inscribed on the board to indicate to the user when each medicinal is to be taken. A length of flexible or elastic material is affixed to the board and interwoven on each side of the board along the ridges or slots to hold the medicinals in place until removed by the user. | 01-20-2011 |
Maxwell Sehested, Kobenhavn DK
Patent application number | Description | Published |
---|---|---|
20120270900 | NOVEL METHOD OF TREATMENT - The present application discloses a method for the treatment or for alleviating the symptoms of a cancer in a subject comprising the steps of a) determining the level of Nicotinic acid phosphoribosyltransferase (NAPRT) in said subject; and b) 1) in the event of a level of NAPRT which is lower than a predetermined threshold value, treating said subject sequentially/simultaneous with i) an effective amount of a nicotinamide phosphoribosyltransferase inhibitor (NAMPRTi), and ii) an effective amount of a nicotinic acid, a nicotinic acid precursor or a prodrug of nicotinic acid; or 2) in the event of a level of NAPRT which is higher than or equal to a predetermined threshold value, treating said subject with i) an effective amount of a NAMPRTi in the absence of sequential/simultaneous treatment with ii) an effective amount of a nicotinic acid, a nicotinic acid precursor or a prodrug of nicotinic acid. | 10-25-2012 |
Maxwell Sehested, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20080213399 | Combination Therapies Using Hdac Inhibitors - The present invention pertains to a method for treating cancer, such as lung cancer, multiple myeloma, lymphoma, and epithelial ovarian cancer, comprising the administration to a patient in need thereof a first amount or dose of a histone deacetylase (HDAC) inhibitor, such as PXD-101, and a second amount or dose of another chemotherapeutic agent, such as dexamethasone or 5-fluorouracil, or an epidermal growth factor receptor (EGFR) inhibitor, such as TarcevaÚ, wherein the first and second amounts or doses together comprise a therapeutically effective amount. | 09-04-2008 |
20090209535 | 6-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY - The present invention relates to certain purines of the following formulae, which act as topoisomerase II catalytic inhibitors: wherein: J is independently: —H or —NR | 08-20-2009 |
20110003777 | Methods of Treatment Employing Prolonged Continuous Infusion of Belinostat - The present invention relates generally to the treatment of diseases and disorders that are mediated by histone deacetylase (HDAC), for example, cancer, with Belinostat™ (also known as (E)-N-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide; PXD101; and PX 105684), and more particularly, to improvement treatments of such diseases (for example, cancers, for example, leukemias), which employ prolonged continuous infusion (e.g., prolonged continuous intravenous infusion) of Belinostat™. | 01-06-2011 |
20140031539 | 6-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY - The present invention relates to certain purines, which act as topoisomerase II catalytic inhibitors. These compounds are useful in combination with topoisomerase II poisons, such as anthracyclines and epipodophyllotoxins, in the treatment of proliferative conditions (e.g., cancer). These compounds are useful in the treatment of tissue damage associated with extravasation of a topoisomerase II poison, such as an anthracycline or an epipodophyllotoxin. | 01-30-2014 |
20150231096 | COMBINATION THERAPIES USING HDAC INHIBITORS - The present invention pertains to a method for treating cancer, such as lung cancer, multiple myeloma, lymphoma, and epithelial ovarian cancer, comprising the administration to a patient in need thereof a first amount or dose of a histone deacetylase (HDAC) inhibitor, such as PXD-101, and a second amount or dose of another chemotherapeutic agent, such as dexamethasone or 5-fluorouracil, or an epidermal growth factor receptor (EGFR) inhibitor, such as TarcevaÚ, wherein the first and second amounts or doses together comprise a therapeutically effective amount. | 08-20-2015 |
Maxwell Shron, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20140164784 | INTEGRATED HEALTH CARE SYSTEMS AND METHODS - Systems and methods described herein may store and analyze patient data sets. A processor in communication with a database may generate a plurality of patient data sets, each of the patient data sets being associated with one of a plurality of patients and comprising an attribute. The processor may de-identify each of the patient data sets so that they are not associated with the patients. The processor may encrypt each of the de-identified data sets to generate a plurality of encrypted data sets and store the encrypted data sets in the database. The processor may analyze one of the patient data sets to determine a relationship between the one of the patient data sets and the other of the patient data sets based on the attribute of the one of the patient data sets and the attributes of the other of the patient data sets. | 06-12-2014 |